Operating Income (Loss) in USD of BioRestorative Therapies, Inc. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BioRestorative Therapies, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • BioRestorative Therapies, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$3.71M, a 62.2% decline year-over-year.
  • BioRestorative Therapies, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$14.5M, a 20.1% decline year-over-year.
  • BioRestorative Therapies, Inc. annual Operating Income (Loss) for 2024 was -$11.6M, a 24.1% increase from 2023.
  • BioRestorative Therapies, Inc. annual Operating Income (Loss) for 2023 was -$15.2M, a 19.8% increase from 2022.
  • BioRestorative Therapies, Inc. annual Operating Income (Loss) for 2022 was -$19M, a 27.9% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

BioRestorative Therapies, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$14.5M -$3.71M -$1.42M -62.2% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 -$13.1M -$3.31M -$836K -33.9% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 -$12.3M -$4.81M -$698K -17% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 -$11.6M -$2.69M +$531K +16.5% 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025
Q3 2024 -$12.1M -$2.29M +$817K +26.3% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$12.9M -$2.47M +$648K +20.8% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$13.6M -$4.11M +$1.67M +28.9% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 -$15.2M -$3.22M +$1.46M +31.2% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025
Q3 2023 -$16.7M -$3.1M +$1.51M +32.7% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$18.2M -$3.12M +$1.51M +32.7% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 -$19.7M -$5.78M -$725K -14.4% 01 Jan 2023 31 Mar 2023 10-Q 11 Jun 2024
Q4 2022 -$19M -$4.68M -$673K -16.8% 01 Oct 2022 31 Dec 2022 10-K/A 11 Jun 2024
Q3 2022 -$18.3M -$4.61M -$921K -25% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$17.4M -$4.63M -$1.07M -30.2% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023
Q1 2022 -$16.3M -$5.05M +$10M +66.4% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$26.3M -$4.01M -$3.15M -366% 01 Oct 2021 31 Dec 2021 10-K 27 Mar 2023
Q3 2021 -$23.2M -$3.69M -$3.08M -504% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$20.1M -$3.56M -$3.09M -670% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$17M -$15.1M -$14.2M -1738% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 -$2.75M -$861K +$1.29M +60.1% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 -$4.05M -$610K +$1.21M +66.5% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$5.26M -$462K +$1.67M +78.3% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$6.92M -$819K +$1.51M +64.8% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 -$8.43M -$2.16M +$22K +1.01% 01 Oct 2019 31 Dec 2019 10-K 30 Apr 2021
Q3 2019 -$8.45M -$1.82M -$630K -53% 01 Jul 2019 30 Sep 2019 10-Q 12 Apr 2021
Q2 2019 -$7.82M -$2.13M -$78.5K -3.83% 01 Apr 2019 30 Jun 2019 10-Q 12 Apr 2021
Q1 2019 -$7.75M -$2.33M -$97.6K -4.38% 01 Jan 2019 31 Mar 2019 10-Q 29 Mar 2021
Q4 2018 -$7.65M -$2.18M -$606K -38.5% 01 Oct 2018 31 Dec 2018 10-K 18 Mar 2021
Q3 2018 -$7.04M -$1.19M +$555K +31.8% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 -$7.6M -$2.05M +$519K +20.2% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 -$8.12M -$2.23M +$259K +10.4% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 -$8.37M -$1.57M +$287K +15.5% 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 -$8.66M -$1.74M -$28.4K -1.66% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018
Q2 2017 -$8.63M -$2.57M -$426K -19.9% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 -$8.21M -$2.49M -$422K -20.4% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$7.79M -$1.86M +$932K +33.4% 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018
Q3 2016 -$8.72M -$1.72M -$225K -15.1% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$8.49M -$2.14M -$880K -69.7% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$7.61M -$2.07M -$441K -27.1% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$7.17M -$2.79M -$1.48M -112% 01 Oct 2015 31 Dec 2015 10-K 22 Mar 2017
Q3 2015 -$5.7M -$1.49M -$594K -66.3% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$5.1M -$1.26M +$18.7K +1.46% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$5.12M -$1.63M -$198K -13.8% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q4 2014 -$4.92M -$1.32M -$107K -8.83% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 -$4.82M -$896K +$233K +20.6% 01 Jul 2014 30 Sep 2014 10-Q 23 Nov 2015
Q2 2014 -$5.05M -$1.28M -$168K -15% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$4.88M -$1.43M -$129K -9.91% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015
Q4 2013 -$4.75M -$1.21M +$494K +29% 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015
Q3 2013 -$5.25M -$1.13M +$76.2K +6.32% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014
Q2 2013 -$5.32M -$1.11M +$225K +16.8% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$5.55M -$1.3M +$24.6K +1.86% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014
Q4 2012 -$5.57M -$1.7M -$1.06M -165% 01 Oct 2012 31 Dec 2012 10-K 11 Apr 2014
Q3 2012 -$4.51M -$1.21M -$352K -41.3% 01 Jul 2012 30 Sep 2012 10-Q 19 Nov 2013
Q2 2012 -$4.16M -$1.34M -$301K -29% 01 Apr 2012 30 Jun 2012 10-Q 19 Aug 2013
Q1 2012 -$3.86M -$1.32M -$307K -30.1% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q4 2011 -$3.55M -$643K 01 Oct 2011 31 Dec 2011 10-K 02 Apr 2013
Q3 2011 -$853K -$483K -130% 01 Jul 2011 30 Sep 2011 10-Q 05 Nov 2012
Q2 2011 -$1.04M -$860K -481% 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012
Q1 2011 -$1.02M 01 Jan 2011 31 Mar 2011 10-Q/A 01 Jun 2012
Q3 2010 -$370K 01 Jul 2010 30 Sep 2010 10-Q 21 Nov 2011
Q2 2010 -$179K 01 Apr 2010 30 Jun 2010 10-Q/A 14 Sep 2011

BioRestorative Therapies, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$11.6M +$3.67M +24.1% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025
2023 -$15.2M +$3.75M +19.8% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025
2022 -$19M +$7.33M +27.9% 01 Jan 2022 31 Dec 2022 10-K/A 11 Jun 2024
2021 -$26.3M -$23.6M -856% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2023
2020 -$2.75M +$5.68M +67.4% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022
2019 -$8.43M -$784K -10.3% 01 Jan 2019 31 Dec 2019 10-K 30 Apr 2021
2018 -$7.65M +$727K +8.68% 01 Jan 2018 31 Dec 2018 10-K 18 Mar 2021
2017 -$8.37M -$589K -7.57% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 -$7.79M -$615K -8.57% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018
2015 -$7.17M -$2.25M -45.7% 01 Jan 2015 31 Dec 2015 10-K 22 Mar 2017
2014 -$4.92M -$170K -3.58% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 -$4.75M +$820K +14.7% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015
2012 -$5.57M -$2.02M -56.9% 01 Jan 2012 31 Dec 2012 10-K 11 Apr 2014
2011 -$3.55M -$1.48M -71.6% 01 Jan 2011 31 Dec 2011 10-K 02 Apr 2013
2010 -$2.07M 01 Jan 2010 31 Dec 2010 10-K 16 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.